Sanofi sells man­u­fac­tur­ing site to Re­ci­pharm; Ap­tose buys rights to sell Crys­talGe­nomic­s' can­cer drug in Chi­na

→ Sanofi is sell­ing off its con­tract res­pi­ra­to­ry drug man­u­fac­tur­ing site in the UK to Re­ci­pharm, which is pick­ing up man­u­fac­tur­ing ca­pac­i­ty as well as …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER